SEC Form 4 · accession 0001162194-15-000076
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mai Chan Yow
Officer — See Remarks
Period of report
Apr 17, 2015
Accepted (ET)
Apr 21, 2015 · 5:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 17, 2015 | M | 4,700 | $15.49 | A | 6,216 | D | |
| Common StockF2 | Apr 17, 2015 | S | 4,700 | $44.0399 | D | 1,516 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $15.49 | Apr 17, 2015 | M | 4,700 | D | — | Feb 17, 2022 | Common Stock | 4,700 | 33,159 | D |
Explanation of responses
- F1The sales reported by Ms. Yow were effected pursuant to a Rule 10b5-1 trading plan adopted on March 3, 2015.
- F2The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $44.00 to $44.355, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F31/48th of the shares subject to the Option vested on February 17, 2012 and 1/48th of the shares subject to the Option vested on March 1, 2012 and each month thereafter, such that the Option will be fully vested on January 1, 2016.
Remarks
EXECUTIVE VP, WORLDWIDE MANUFACTURING & MANAGING DIRECTOR - SINGAPORE